Form 8-K OncoMed Pharmaceuticals For: Nov 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Wall St set to open higher as jobs data dampens rate hike odds, yields fall
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
OncoMed Pharma (OMED) Misses Q3 EPS by 4c
November 5, 2015 9:20 AM ESTOncoMed Pharma (NASDAQ: OMED) reported Q3 EPS of ($0.81), $0.04 worse than the analyst estimate of ($0.77).
For earnings history and earnings-related data on OncoMed Pharma (OMED) click here.
... More